MedPath

The future of coeliac disease: immunology, environment and possibilities for new treatments.

Recruiting
Conditions
Coeliac sprue
Gluten intolerance
10025477
10003816
Registration Number
NL-OMON44841
Lead Sponsor
eids Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
400
Inclusion Criteria

All children that undergo diagnostic upper gastrointestinal endoscopy under general anesthesia for medical reasons in the Willem-Alexander Children*s Hospital of the LUMC are eligible for the study. Around 120 children undergo upper gastrointestinal endoscopy in the Department of Pediatrics of the LUMC each year. They will be divided in
- Cases: all children that are diagnosed with coeliac disease according to accepted criteria
- Controls: all children that are diagnosed with other conditions unrelated to coeliac disease ;Informed consent and suffiecient knowledge / understanding of the Dutch language are mandatory

Exclusion Criteria

- No informed consent
- Insufficient knowledge / understanding of Dutch language
- Prior participation in protocol P06.140 or the present study if subject has undergone more than one endoscopy.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Definition of the disease associated T cell receptor repertoire in a large<br /><br>group of paediatric patients.<br /><br>Determination of the functional characteristics of the disease associated T<br /><br>cells.<br /><br>Correlation of the disease associated T cell receptor repertoire with disease<br /><br>onset and/or severity<br /><br>Phenotypic and functional characterisation of the intraepithelial lymphocyte<br /><br>compartment in patients with and without CD.<br /><br>Analysis of the cytokine mediated crosstalk between the lamina propria and<br /><br>epithelial compartments.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Ultimately we aim to develop novel diagnostics and preventive and therapeutic<br /><br>approaches for CD.</p><br>
© Copyright 2025. All Rights Reserved by MedPath